186 related articles for article (PubMed ID: 24507862)
1. Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
Koo DL; Hwang KJ; Han SW; Kim JY; Joo EY; Shin WC; Lee HW; Seo DW; Hong SB
Epilepsy Res; 2014 Mar; 108(3):442-7. PubMed ID: 24507862
[TBL] [Abstract][Full Text] [Related]
2. Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
Koo DL; Joo EY; Kim D; Hong SB
Epilepsy Res; 2013 Mar; 104(1-2):134-9. PubMed ID: 23032070
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
Mintzer S; Boppana P; Toguri J; DeSantis A
Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy.
Triantafyllou N; Lambrinoudaki I; Armeni E; Evangelopoulos EM; Boufidou F; Antoniou A; Tsivgoulis G
J Neurol Sci; 2010 Mar; 290(1-2):131-4. PubMed ID: 20056251
[TBL] [Abstract][Full Text] [Related]
5. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy.
Kim SH; Lee JW; Choi KG; Chung HW; Lee HW
Epilepsy Behav; 2007 Mar; 10(2):291-5. PubMed ID: 17224308
[TBL] [Abstract][Full Text] [Related]
6. Effects of zonisamide monotherapy on bone health in drug-naive epileptic patients.
Koo DL; Nam H
Epilepsia; 2020 Oct; 61(10):2142-2149. PubMed ID: 32944954
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy.
Beerhorst K; Tan IY; De Krom M; Verschuure P; Aldenkamp AP
Acta Neurol Scand; 2013 Oct; 128(4):273-80. PubMed ID: 23461582
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
[TBL] [Abstract][Full Text] [Related]
9. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.
Pack AM; Morrell MJ; Randall A; McMahon DJ; Shane E
Neurology; 2008 Apr; 70(18):1586-93. PubMed ID: 18443309
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of antiepileptic drugs on bone mineral density.
Babayigit A; Dirik E; Bober E; Cakmakci H
Pediatr Neurol; 2006 Sep; 35(3):177-81. PubMed ID: 16939856
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density in adult patients treated with various antiepileptic drugs.
Beniczky SA; Viken J; Jensen LT; Andersen NB
Seizure; 2012 Jul; 21(6):471-2. PubMed ID: 22541979
[TBL] [Abstract][Full Text] [Related]
12. BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy.
Lambrinoudaki I; Kaparos G; Armeni E; Alexandrou A; Damaskos C; Logothetis E; Creatsa M; Antoniou A; Kouskouni E; Triantafyllou N
Eur J Neurol; 2011 Jan; 18(1):93-8. PubMed ID: 20500803
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density following long-term use of antiepileptic drugs in a tropical Asian country.
Phabphal K; Limapichat K; Sathirapanya P; Setthawatcharawanich S; Leelawattana R; Thammakumpee N; Thamaprasit A; Geater A
Epileptic Disord; 2008 Sep; 10(3):213-8. PubMed ID: 18782690
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
Chou IJ; Lin KL; Wang HS; Wang CJ
Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy.
Tsukahara H; Kimura K; Todoroki Y; Ohshima Y; Hiraoka M; Shigematsu Y; Tsukahara Y; Miura M; Mayumi M
Pediatr Int; 2002 Jun; 44(3):247-53. PubMed ID: 11982890
[TBL] [Abstract][Full Text] [Related]
16. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
Kim DW; Lee SY; Shon YM; Kim JH
Epilepsia; 2013 Oct; 54(10):e146-9. PubMed ID: 23980720
[TBL] [Abstract][Full Text] [Related]
17. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
18. The effect of oxcarbazepine on bone metabolism.
Cetinkaya Y; Kurtulmuş YS; Tutkavul K; Tireli H
Acta Neurol Scand; 2009 Sep; 120(3):170-5. PubMed ID: 19719808
[TBL] [Abstract][Full Text] [Related]
19. Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study.
Bauer S; Hofbauer LC; Rauner M; Strzelczyk A; Kellinghaus C; Hallmeyer-Elgner S; Oertel WH; Rosenow F
Epilepsy Res; 2013 Oct; 106(3):417-22. PubMed ID: 23916144
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine and bone loss in epilepsy.
Elliott JO; Jacobson MP; Haneef Z
Seizure; 2007 Jan; 16(1):22-34. PubMed ID: 17110134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
